soul trial oral semaglutide cardiovascular outcomes 2024 results nejm reduced the risk of clinically important kidney and death from (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 ๐ธ๐ช #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 soul trial oral semaglutide cardiovascular
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 12 - Aug 17




























![Monkey.D.Garp (Alternate Art) [Paramount War] GG41](https://cdn.shopify.com/s/files/1/0518/7613/5111/files/1a533c0e-e6dc-5385-a050-b51ec14e2f7c_5bd747ed-7907-4f3f-89a1-ae9583a7020a.jpg?v=1719236831)

